Skin Even IQ (pack 4/5: Skin CoQ10+)
Food supplement declared in France, declaration No 2023-5-812, decision dated 17 May 2023
Skin Even IQ (pack 4/5: Skin CoQ10+), from iiaa Ltd., is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Pinus pinaster 25 mg per day, Ubiquinone. None of the rules we check flags an issue with its declared composition.
- Brand
- not provided
- Food business operator placing the product on the market
- iiaa Ltd.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 gélule
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Taking away from meals, Pregnant women, Taking anticoagulants, Prolonged use
Declaration 243586, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Pinus pinaster Aiton | Ecorce | Autre extrait sec | 25 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Ubiquinone | not declared |
Additives
E150c, Hydroxypropyl Méthyl Cellulose
Other ingredients
Oryza sativa L.
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Tenir hors de portée des jeunes enfants. Les compléments alimentaires ne doivent pas se substituer à une alimentation variée et équilibrée et à un mode de vie sain. Ne pas utiliser pendant plus de 6 semaines sans avis médical. Ne consommez pas 800 mg ou plus de (-)-epigallocatéchine-3-gallate par jour. Ne doit pas être consommé si vous prenez le même jour d’autres produits contenant du thé vert. Ne doit pas être consommé par les femmes enceintes ou allaitantes et par les enfants de moins de 18 ans. Ne doit pas être consommé à jeun. L'emploi chez les personnes sous anticoagulant est déconseillé. Déconseillé aux femmes ménopausées. Le bêta-carotène est déconseillé aux fumeurs.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ubiquinone
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Skin Even IQ (pack 4/5: Skin CoQ10+): composition and regulation”, https://compoatlas.com/en/supplements/products/243586-skin-even-iq-pack-4-5-skin-coq10, updated 15 November 2026.